# GEICAM Spanish Breast Cancer Group

Source: https://onco.cc/companies/geicam/  
OnCo record `geicam` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Spain's national breast cancer research group, running adjuvant chemotherapy, endocrine and CDK4/6 inhibitor trials across more than 200 hospitals.

## Summary

Founded in 1995, GEICAM brings together Spain's breast cancer investigators and has enrolled tens of thousands of patients in academic trials. GEICAM 9906 and 9805 shaped adjuvant taxane use, CIBOMA tested maintenance capecitabine in triple-negative disease, and PARSIFAL and FLIPPER studied palbociclib partners in hormone receptor-positive metastatic cancer. GEICAM co-runs global trials with the Breast International Group and the US cooperative groups and maintains the El Álamo registry and a tumour bank. Its chairman is a member of the OnCo people corpus.

## Fields

- Kind: Company
- Last checked: 2026-09-09
- Also known as: GEICAM; Grupo Español de Investigación en Cáncer de Mama
- Tags: cooperative-group
- HQ: Madrid
- Type: cooperative-group
- Website: https://www.geicam.org

## Notes

- Adjuvant chemotherapy trials (GEICAM 9906, 9805)
- CDK4/6 inhibitor trials (PARSIFAL, FLIPPER)
- El Álamo registry and biobank
- BIG member group

## Sources

- GEICAM: https://www.geicam.org
- Clinical trials (archived copy): https://web.archive.org/web/20211020135241/https://www.geicam.org/en/clinical-trials

## Connected records

- drugs: [Palbociclib](https://onco.cc/drugs/palbociclib/)
- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Hormonal Therapy](https://onco.cc/fronts/hormonal/)
- technologies: [CDK4/6 inhibitors](https://onco.cc/technologies/cdk46-inhibitor/), [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Endocrine therapy (SERMs, AIs, SERDs)](https://onco.cc/technologies/endocrine-therapy/)
- companies: [Breast International Group (BIG)](https://onco.cc/companies/big/), [SOLTI Cancer Research Group](https://onco.cc/companies/solti/)
- institutions: [Hospital General Universitario Gregorio Marañón](https://onco.cc/institutions/gregorio-maranon/)
- people: [Ander Urruticoechea](https://onco.cc/people/ander-urruticoechea/), [Miguel Martín](https://onco.cc/people/miguel-martin/), [Sara López-Tarruella](https://onco.cc/people/sara-lopez-tarruella/)
- trials: [GEICAM/2003-11_CIBOMA/2004-01](https://onco.cc/trials/geicam-ciboma/)

---
JSON: https://onco.cc/api/v1/entities/geicam.json